Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis

被引:101
作者
Vergis, EN
Shankar, N
Chow, JW
Hayden, MK
Snydman, DR
Zervos, MJ
Linden, PK
Wagener, MM
Muder, RR
机构
[1] Univ Pittsburgh, Med Ctr, Vet Affairs Med Ctr, Infect Dis Sect, Pittsburgh, PA 15260 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Med Chem & Pharmaceut, Oklahoma City, OK USA
[3] Rush Presbyterian St Lukes Med Ctr, Rush Med Coll, Infect Dis Sect, Chicago, IL 60612 USA
[4] Wayne State Univ, Sch Med, John D Dingel Vet Affairs Med Ctr, Div Infect Dis, Detroit, MI USA
[5] William Beaumont Hosp, Royal Oak, MI 48072 USA
[6] Tufts Univ, Sch Med, Boston, MA 02111 USA
[7] Tufts Univ New England Med Ctr, Div Infect Dis, Boston, MA 02111 USA
关键词
D O I
10.1086/341977
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The potential virulence factors of enterococci include production of enterococcal surface protein (Esp), gelatinase, and hemolysin. Gelatinase- and hemolysin-producing strains of Enterococcus faecalis have been shown to be virulent in animal models of enterococcal infections. Esp production has been shown to enhance the persistence of E. faecalis in the urinary bladder. We determined the presence of the esp gene and production of gelatinase and hemolysin in 219 E. faecalis isolates from a larger prospective study of 398 patients with enterococcal bacteremia. Thirty-two percent of isolates carried the esp gene, 64% produced gelatinase, and 11% produced hemolysin. There was no significant association between 14-day mortality and any of the markers studied, singly or in combination.
引用
收藏
页码:570 / 575
页数:6
相关论文
共 27 条
  • [1] Vancomycin-resistant enterococci
    Cetinkaya, Y
    Falk, P
    Mayhall, CG
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) : 686 - +
  • [2] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590
  • [3] PLASMID-ASSOCIATED HEMOLYSIN AND AGGREGATION SUBSTANCE PRODUCTION CONTRIBUTE TO VIRULENCE IN EXPERIMENTAL ENTEROCOCCAL ENDOCARDITIS
    CHOW, JW
    THAL, LA
    PERRI, MB
    VAZQUEZ, JA
    DONABEDIAN, SM
    CLEWELL, DB
    ZERVOS, MJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) : 2474 - 2477
  • [4] INCIDENCE OF HEMOLYSIN, GELATINASE, AND AGGREGATION SUBSTANCE AMONG ENTEROCOCCI ISOLATED FROM PATIENTS WITH ENDOCARDITIS AND OTHER INFECTIONS AND FROM FECES OF HOSPITALIZED AND COMMUNITY-BASED PERSONS
    COQUE, TM
    PATTERSON, JE
    STECKELBERG, JM
    MURRAY, BE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) : 1223 - 1229
  • [5] Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis
    Dupont, H
    Montravers, P
    Mohler, J
    Carbon, C
    [J]. INFECTION AND IMMUNITY, 1998, 66 (06) : 2570 - 2575
  • [6] GUTSCHIK E, 1979, ACTA PATH MICRO IM B, V87, P353
  • [7] ANTIBIOTIC-THERAPY FOR PSEUDOMONAS-AERUGINOSA BACTEREMIA - OUTCOME CORRELATIONS IN A PROSPECTIVE-STUDY OF 200 PATIENTS
    HILF, M
    YU, VL
    SHARP, J
    ZURAVLEFF, JJ
    KORVICK, JA
    MUDER, RR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 87 (05) : 540 - 546
  • [8] BACTEREMIA CAUSED BY HEMOLYTIC, HIGH-LEVEL GENTAMICIN-RESISTANT ENTEROCOCCUS-FAECALIS
    HUYCKE, MM
    SPIEGEL, CA
    GILMORE, MS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) : 1626 - 1634
  • [9] HEMOLYSIN OF STREPTOCOCCUS-FAECALIS SUBSPECIES ZYMOGENES CONTRIBUTES TO VIRULENCE IN MICE
    IKE, Y
    HASHIMOTO, H
    CLEWELL, DB
    [J]. INFECTION AND IMMUNITY, 1984, 45 (02) : 528 - 530
  • [10] HIGH-INCIDENCE OF HEMOLYSIN PRODUCTION BY ENTEROCOCCUS-(STREPTOCOCCUS)-FAECALIS STRAINS ASSOCIATED WITH HUMAN PARENTERAL INFECTIONS
    IKE, Y
    HASHIMOTO, H
    CLEWELL, DB
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (08) : 1524 - 1528